Liang WangORCID icon for 0000-0001-5339-7484

Guangdong Provincial People's Hospital China

Prof. Liang Wang currently holds a tenured full professorship and a distinguished medical researcher position at Guangdong Provincial People’s Hospital, a top-tier tertiary hospital at the national level, which is affiliated with the Southern Medical University and the South China University of Technology in China. Prof. Wang also holds adjunct research fellow positions at the University of Queensland and the University of Western Australia, and an adjunct associate professorship position at Edith Cowan University. His research centers on advancing disease diagnosis via interdisciplinary methods such as intelligent medicine, digital health, laboratory medicine, analytical chemistry, and molecular biology. Prof. Wang has edited seven books and published over 130 peer-reviewed articles in esteemed journals such as The Lancet Microbe, npj Digital Medicine, Trends in Analytical Chemistry, and ISME J. Prof. Wang frequently presents at prestigious conferences like EuroCarb (Poland, 2025), ICDM (Republic of Korea, 2025), ICID (South Africa, 2024), CHRO (Australia, 2024) and VAAM (Germany, 2023), etc. He also serves as an editorial board member for multiple international journals, including Journal of Applied Microbiology (Lead Editor, Health and Diseases Theme), Journal of Translational Medicine (Associate Editor, Computational Modeling and Epidemiology Theme), Frontiers in Microbiology (Associate Editor, Systems Microbiology Theme), and BMC Microbiology (Editor of Distinction Awards, 2025). He is the recipient of the American Chemical Society’s Rising Star Award in Measurement Science (2025) and the Australia-China Helicobacter Research Fellowship (2017).

Liang Wang

3books edited

3chapters authored

Latest work with IntechOpen by Liang Wang

Mycobacteria comprise a vast group of obligate and opportunistic pathogens. The genus Mycobacterium is primarily divided into three groups: the Mycobacterium tuberculosis complex (MTBC), Nontuberculous mycobacteria (NTM), and Mycobacterium leprae. MTBC includes Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium canettii, among others. Approximately 98% of human tuberculosis (TB) cases are caused by M. tuberculosis. Currently, TB still poses significant challenges to global health. According to the World Health Organization, an estimated 10.8 million people fell ill with TB worldwide in 2023, among whom 1.25 million people died from the disease. The United Nations Sustainable Development Goals (SDGs) put ending the TB epidemic by 2030 among its health targets. As for NTM, also known as atypical mycobacteria, they are a group of bacteria found in natural environments worldwide, including soil, dust, and water. Unlike MTBC, which causes contagious diseases, NTM infections primarily affect the lungs, skin, and soft tissues, with no general contagion. However, the symptoms of NTM infection may be similar to those of MTBC, making it challenging to distinguish between MTBC and NTM infections. Therefore, rapid diagnosis and precision treatment of mycobacterial infections are essential for the effective control and efficient eradication of these bacterial pathogens. In this book, the authors focused on the various aspects of the mycobacterial species, providing updated knowledge about phylogenetic analysis, antibiotic resistance, rapid diagnosis, and treatment strategies of these bacterial pathogens. The integration of computational analysis and experimental evidence presented in this book will make it a reliable guideline for both microbiological researchers and healthcare providers seeking updated information on the diagnosis and treatment of mycobacterial infections.

Go to the book